Nuveen Asset Management, LLC Repare Therapeutics Inc. Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$9.32 - $15.06 $20,653 - $33,372
2,216 Added 10.25%
23,846 $234,000
Q4 2022

Feb 14, 2023
SELL
$12.5 - $18.13 $2,350 - $3,408
-188 Reduced 0.86%
21,630 $318,000
Q3 2022

Nov 14, 2022
BUY
$11.57 - $15.59 $7,636 - $10,289
660 Added 3.12%
21,818 $265,000
Q2 2022

Aug 15, 2022
BUY
$8.45 - $14.84 $178,785 - $313,984
21,158 New
21,158 $296,000

Others Institutions Holding RPTX

# of Institutions
62
Shares Held
35.4M
Call Options Held
50K
Put Options Held
300
View Full List

About Repare Therapeutics Inc.

RPTX Quotes by TradingView
  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $57.9M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email